Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Aiforia Technologies

3,36

 

EUR

 

+0,6 %

2.006 følger denne virksomhed

AIFORIA

First North Finland

Medical Equipment & Services

Health Care

Overview
Finansielt overblik og estimater
Investor consensus
Sammenligne
+0,6%
+2,13%
-2,04%
-6,67%
-4,27%
-25,66%
-12,73%
-
-33,6%

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of areas from oncology to neuroscience. Aiforia Technologies is headquartered in Finland.

Læs mere
Markedsværdi
106,2 mio. EUR
Aktieomsætning
35,25 t EUR
P/E (adj.) (25e)
-8,99
EV/EBIT (adj.) (25e)
-8,78
P/B (25e)
7,46
EV/S (25e)
22,21
Udbytteafkast, % (25e)
-
Coverage
Anbefaling
Akkumulér
Kursmål
4.20 EUR
Opdateret
23.04.2025
Disclaimer
Frans-Mikael Rostedt
Antti Luiro
Antti Luiro, Frans-Mikael Rostedt
Vis mere
Seneste analyse

Seneste analyse

Released: 24.04.2025

Seneste omfattende analyse

Released: 24.04.2025

Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
28.8
2025

Delårsrapport Q2'25

Risiko
Business risk
Valuation risk
Lav
Høj
Alle
Analyse
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelsei går

Aiforia to publish January–June 2025 Half-year Financial Report on August 28, 2025

Aiforia Technologies
Selskabsmeddelelsei går

Change in Aiforia Technologies Plc’s Management Team

Aiforia Technologies
Aiforia, Webcast, Q2'25
Videopræsentation28.8.2025, 10.00

Aiforia, Webcast, Q2'25

Aiforia Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Aiforia establishes a subsidiary in France
Analytikerkommentar10.7.2025, 07.20 af
Frans-Mikael Rostedt, Antti Luiro

Aiforia establishes a subsidiary in France

Aiforia has had a sales organization in France since 2023, and the newly formed subsidiary will strengthen the company's local presence and support its growing business in the country.

Aiforia Technologies
Pressemeddelelse9.7.2025, 06.00

Aiforia establishes a subsidiary in France to strengthen its position in the European market

Aiforia Technologies
Selskabsmeddelelse2.7.2025, 14.00

Aiforia Technologies Plc – Managers’ Transactions – Joseph Bernardo

Aiforia Technologies
Selskabsmeddelelse25.6.2025, 06.00

Aiforia Technologies Plc: Share subscriptions based on stock options 2016 B, 2020 I ja 2021 I

Aiforia Technologies
Selskabsmeddelelse24.6.2025, 15.30

The Board of Directors of Aiforia Technologies Plc decided on new Stock Option Plan

Aiforia Technologies
Analytikerkommentar24.6.2025, 10.49 af
Antti Luiro, Frans-Mikael Rostedt

Aiforia's product portfolio expands with new CE-IVD approved solution for breast cancer diagnostics

This solution is Aiforia's ninth to receive CE-IVD approval in Europe. However, unlike previous approvals, the solution includes five separate AI models, so the approval significantly expands the company's product portfolio (8 models + 1 viewer -> 13 models + 1 viewer). The approval increases the potential scale of the company's new customer agreements and also enables larger expansions for existing customers.

Aiforia Technologies
Pressemeddelelse24.6.2025, 06.00

Aiforia releases a new CE-IVD-marked clinical AI solution for breast cancer diagnostics

Aiforia Technologies
Aiforia Technologies: Valuable reference in France10:18
Video17.6.2025, 13.34 af
Antti Luiro

Aiforia Technologies: Valuable reference in France

Aiforia’s CEO Jukka Tapaninen provides an update on what is currently happening in the company in an interview with analyst Antti Luiro. Topics include new customers, ongoing negotiations, and expansion to new models for existing customers.

Aiforia Technologies
Selskabsmeddelelse30.5.2025, 15.00

Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act - Sto-Rahoitus Oy’s holding in Aiforia Technologies Plc

Aiforia Technologies
Selskabsmeddelelse30.5.2025, 09.00

Aiforia Technologies Plc – Managers’ Transactions – Tuomas Tenkanen

Aiforia Technologies
Selskabsmeddelelse30.5.2025, 08.00

Aiforia Technologies Plc – Managers’ Transactions – Jukka Tapaninen

Aiforia Technologies
Selskabsmeddelelse29.5.2025, 08.30

Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act - Ascend Tapio Sarl’s holding in Aiforia Technologies Plc

Aiforia Technologies
Selskabsmeddelelse28.5.2025, 13.00

A total of 2,502,187 new shares in Aiforia Technologies Plc registered with the Trade Register

Aiforia Technologies
Analytikerkommentar28.5.2025, 06.22 af
Antti Luiro, Frans-Mikael Rostedt

Aiforia raised 8 MEUR in an expected directed issue

The issue was fully expected, as we believe the company’s implementation of its growth strategy requires additional funding to be collected this year. The terms (EUR 3.2 per share, gross proceeds of some 8 MEUR) were quite well in line with our expectations.

Aiforia Technologies
Selskabsmeddelelse27.5.2025, 20.30

Inside information: Aiforia Technologies Plc successfully completes a directed share issue raising EUR 8 million

Aiforia Technologies
Selskabsmeddelelse27.5.2025, 15.31

Inside information: Aiforia Technologies Plc intends to carry out a directed share issue by means of an accelerated bookbuilding proces

Aiforia Technologies
Pressemeddelelse26.5.2025, 07.00

Aiforia appoints Richard Doughty as Medical Director

Aiforia Technologies
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team